Skip to content

Clinical trials

Phase 1/2 Uterine Cervical Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 1/2 Country / region: South Korea Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20161
20183
20191
20202
20213
20222
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting4
Recruiting4
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
Ascendis Pharma Oncology Division A/S1
AstraZeneca1
Cellid Co., Ltd.1
GI Innovation, Inc.1
GeneMedicine Co., Ltd.1
Genexine, Inc.1
Klus Pharma Inc.1
Korea Cancer Center Hospital1
Medicenna Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms17
Carcinoma, Non-Small-Cell Lung6
Squamous Cell Carcinoma of Head and Neck6
Breast Neoplasms5
Colorectal Neoplasms5
Carcinoma, Renal Cell4
Endometrial Neoplasms4
Neoplasm Metastasis4
Ovarian Neoplasms4
Stomach Neoplasms4

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.